Received: 15 May 2020
Accepted: 25 November 2020
First Online: 4 December 2020
Ethics approval and consent to participate
: De-identified clinical biospecimens were obtained subsequent to COVID-19 testing at the University of Minnesota under a protocol approved by the University of Minnesota Institutional Review Board (FWA number 00000312): “Detection of COVID 19 by Molecular Methods” (STUDY00009560). The need for informed consent was deemed unnecessary by the IRB. The IRB panel used “WORKSHEET: Human Research (HRP-310)” to make the determination that this study was exempt as not human research as defined by DHHS regulations.
: Not applicable.
: The authors declare that they have no competing interests.